MolDrug logo — Chemoinformatics and modeling solutions to optimize your dru...

MolDrug

Chemoinformatics and modeling solutions to optimize your drug candidates.

Founded 2018 Spain Spain 3 employees Non Equity Assistance Marketing, Wellness Beauty

General Information

Company Name MolDrug
Founded Year 2018
Location Spain Spain +3
Employees 3
Industries Marketing, Wellness Beauty
Funding Stage Non Equity Assistance
Social

Get notified when MolDrug moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MolDrug

MolDrug is a Chemoinformatics and modeling solution company aimed at optimizing drug candidates. The company, which is a part of ProtoQSAR, specializes in designing and optimizing molecules using Machine Learning-powered chemoinformatics and structural bioinformatics. MolDrug's models enable the prediction of molecular properties (QSAR) and detailed interaction analyses (molecular modeling) for various compound types. This includes small molecules, peptides, nanomaterials, and mixtures. The technology offers benefits such as faster results, cost and resource savings, reduced animal testing, and regulatory validity. Founded in 2018 and headquartered in Spain, MolDrug caters to industries including Marketing, Wellness Beauty, as well as the chemical sector and the pharma/biotech/drug development sector. Its most recent investment was a Non Equity Assistance investment received on 31 January 2024 from StartBEC.

Taxonomy: Chemoinformatics, Modeling solutions, Drug candidates optimization, Machine Learning-powered chemoinformatics, Structural bioinformatics, Molecular properties prediction, QSAR, Molecular modeling, Physicochemical properties assessment, Biological properties assessment, Pharmacological properties assessment, Toxicological properties assessment, Regulatory toxicology, Pharma sector optimization, Biotech sector optimization

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance •••••• 1
Investor
31 Jan 2024

MolDrug Alternatives & Competitors

MolDrug vs

SWITCH Materials develops revolutionary new materials based on proprietary organic molecules that "s...

Secondary Market
1 employees
Food and Beverage, Health Care
MolDrug vs

Unifying AI and Biotech to accelerate the discovery of new medicines

Unknown
162 employees
AI, Biotechnology
MolDrug vs

YOUR DREAM STARTS HERE!

5 employees
Prop Tech, Real Estate

FAQ About MolDrug

Chemoinformatics and modeling solutions to optimize your drug candidates.
MolDrug was founded in 2018.
MolDrug is headquartered in Spain.
MolDrug operates in the following industries: Marketing, Wellness Beauty.
MolDrug has approximately 3 employees.
MolDrug has completed 1 funding round. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to MolDrug include SWITCH Materials, Genesis Molecular AI, Presprop Portugal Construction, Molecular Quantum Solutions, Rayca Precision. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MolDrug and SWITCH Materials are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MolDrug and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy